-
EP2097079
European procedure
Extract from the Register of European Patents
EP About this file: EP2097079
| EP2097079 - MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.05.2013 Database last updated on 26.06.2024 | Most recent event Tooltip | 03.05.2013 | No opposition filed within time limit | published on 05.06.2013 [2013/23] | Applicant(s) | For all designated states Hunter-Fleming Limited Regus House, 1 Friary, Temple Quay Bristol BS1 6EA / GB | [2009/37] | Inventor(s) | 01 /
WÜLFERT, Ernst Avenue des Aubepines 52 1180 Brussels / BE | [2012/13] |
| Former [2009/37] | 01 /
WüLFERT, Ernst Avenue des Aubepines 52 1180 Brussels / BE | Representative(s) | Mancini, Vincenzo, et al Giambrocono & C. s.p.a., Via Rosolino Pilo 19/B 20129 Milano / IT | [2010/32] |
| Former [2009/37] | Fairbairn, Angus Chisholm Marks & Clerk LLP 90 Long Acre London WC2E 9RA / GB | Application number, filing date | 07870407.9 | 29.11.2007 | [2009/37] | WO2007GB04584 | Priority number, date | GB20060023971 | 30.11.2006 Original published format: GB 0623971 | US20060867873P | 30.11.2006 Original published format: US 867873 P | [2009/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008065408 | Date: | 05.06.2008 | Language: | EN | [2008/23] | Type: | A2 Application without search report | No.: | EP2097079 | Date: | 09.09.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.06.2008 takes the place of the publication of the European patent application. | [2009/37] | Type: | B1 Patent specification | No.: | EP2097079 | Date: | 27.06.2012 | Language: | EN | [2012/26] | Search report(s) | International search report - published on: | EP | 20.11.2008 | Classification | IPC: | A61K31/403, A61K31/407, A61K31/437, A61K31/57, A61K31/566, A61K31/568, A61K31/5685, A61P1/00, A61P3/10, A61P9/00, A61P11/06, A61P17/02, A61P25/02, A61P25/28, A61P29/00 | [2009/37] | CPC: |
A61K31/568 (EP,KR,US);
A61K31/403 (KR);
A61K31/566 (EP,US);
A61K31/5685 (EP,KR,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P13/12 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P9/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/37] | Extension states | AL | 15.05.2009 | BA | 15.05.2009 | HR | 15.05.2009 | MK | 15.05.2009 | RS | 15.05.2009 | Title | German: | MODULIERUNG DES PROSTAGLANDIN/CYCLOOXYGENASE-METABOLISMUS | [2012/01] | English: | MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS | [2009/37] | French: | MODULATION DES VOIES MÉTABOLIQUES DE LA PROSTAGLANDINE/CYCLOOXYGÉNASE | [2009/37] |
| Former [2009/37] | MODULATION DER STOFFWECHSELPFADE VON PROSTAGLANDIN/CYCLOOXYGENASE | Entry into regional phase | 15.05.2009 | National basic fee paid | 15.05.2009 | Designation fee(s) paid | 15.05.2009 | Examination fee paid | Examination procedure | 18.05.2009 | Examination requested [2009/37] | 12.08.2009 | Amendment by applicant (claims and/or description) | 13.04.2011 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.2011 | Reply to a communication from the examining division | 28.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 04.11.2011 | Reply to a communication from the examining division | 02.03.2012 | Communication of intention to grant the patent | 09.05.2012 | Fee for grant paid | 09.05.2012 | Fee for publishing/printing paid | Divisional application(s) | EP09012181.5 / EP2147673 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.04.2011 | Opposition(s) | 28.03.2013 | No opposition filed within time limit [2013/23] | Fees paid | Renewal fee | 12.11.2009 | Renewal fee patent year 03 | 24.11.2010 | Renewal fee patent year 04 | 23.11.2011 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]NL7100213 (ORGANON N.V.) [X] 1 * the whole document * * examples A,B,I-IV *; | [X]WO0160375 (HUNTER FLEMING LTD [GB], et al) [X] 1 * abstract *; | [DX]WO0200224 (HUNTER FLEMING LTD [GB], et al) [DX] 1-6,18,27-29 * the whole document * * claim 4 *; | [X]GB2378898 (HUNTER FLEMING LTD [GB]) [X] 1-6,18,23,24,27,28 * abstract ** page 15, lines 7-25; example 22 *; | [X]FR2829697 (MAYOLY SPINDLER LAB [FR]) [X] 1 * abstract * * page 4, line 10 - page 6, line 17 * * page 7, lines 3-8 *; | [X]WO2005079810 (UNIV EDINBURGH [GB], et al) [X] 1,2,4-6,18-23,27,28 * abstract * * page 3, paragraph 4 - page 5, paragraph 1; examples 1-5; claims 1-21 * | by applicant | NL7100213 | WO0160375 | WO0200224 | WO0200225 | GB2378898 | WO03015791 | FR2829697 | WO2005079810 |